Ms. Norma K. Biln is on the Board of Directors at Resverlogix Corp. and Augurex Life Sciences Corp. Ms. Biln was previously employed as a Principal by Abbott Laboratories, a Principal by Amgen, Inc., Chairman by BioTalent Canada, a Principal by Pfizer Pharmaceuticals, Inc., and Director-Sales & Marketing by Stressgen Bioreagents Corp.
She received her undergraduate degree from McGill University.
Ms. Biln is an past competitor in the NVBC Competition.
